Auf dieser Seite
ATOS Atossa Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 7, 2026
$2,34
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$1,7052-Wochen-Tief
$19,3552-Wochen-Hoch
Marktkapitalisierung (MRQ)
$23M
P/E
-0.6
EPS
$-4.04
Ihre Abzeichen
52W-Spanne
$2–$19
Analystenbewertung
BUY
Kursziel
$19
P/E
-0.6
ROE
-71.7%
Nettogewinnmarge
·
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
ATOS Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$2.34
Marktkapitalisierung (MRQ)
$23M
P/E
-0.6
EPS
$-4.04
ROE
-71.7%
52W-Spanne
$2–$19
ATOS Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 2. Februar 2026 | 1-for-15 | Umgekehrt |
| 20. April 2018 | 1-for-12 | Umgekehrt |
| 26. August 2016 | 1-for-15 | Umgekehrt |
Über Atossa Therapeutics, Inc. - Common Stock Unternehmensübersicht von Wikipedia
SektorHealthcare
BrancheBiotechnology
Mitarbeiter16
LandUS
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
EPS$-4.042022-12-31 → 2025-12-31
Freier Cashflow$-30M2018-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | ATOS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | -0.65-Jahres-Durchschnitt ≈-1.7 | ≈-1.7 | · | · | |
| P/S | 176.75-Jahres-Durchschnitt ≈888.4 | ≈888.4 | 62.2 | Unterbewertet | |
| K/B (MRQ) | 0.95-Jahres-Durchschnitt ≈1.0 | ≈1.0 | 1.1 | Unterbewertet | |
| Kurs / FCF (TTM) | -0.75-Jahres-Durchschnitt ≈-5.3 | ≈-5.3 | · | · | |
| Kurs / Cashflow (TTM) | -0.75-Jahres-Durchschnitt ≈-5.3 | ≈-5.3 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 0.55-Jahres-Durchschnitt ≈1.0 | ≈1.0 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | ATOS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| ROA | -56.1%5-Jahres-Durchschnitt ≈-31.1% | ≈-31.1% | -56.1% | Im Einklang | |
| ROE | -71.7%5-Jahres-Durchschnitt ≈-35.1% | ≈-35.1% | -128.2% | Spitzenklasse | |
| ROIC | -94.4%5-Jahres-Durchschnitt ≈-41.2% | ≈-41.2% | -77.4% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | ATOS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 5.75-Jahres-Durchschnitt ≈20.9 | ≈20.9 | 2.1 | Starke Liquidität | |
| Quick Ratio | 5.05-Jahres-Durchschnitt ≈20.0 | ≈20.0 | 1.6 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-8.6%
Nächster Bericht
Nov 10, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 10, 2026 | $-0.95 | $-1.05 | 9.1% |
| 31. März 2026 | Mai 11, 2026 | $-1.11 | $-6.25 | 82.2% |
| 31. Dezember 2025 | $-3.08 | $-1.16 | -165.4% | |
| 30. September 2025 | $-1.05 | $-1.02 | -2.9% | |
| 30. Juni 2025 | $-1.05 | $-0.88 | -19.3% | |
| 31. März 2025 | $-0.75 | $-0.87 | 13.5% | |
| 31. Dezember 2024 | $-0.75 | $-0.97 | 22.6% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | $1.8K | $40.1K | |
| Cost of Revenue | · | · | · | · | · | · | · | · | · | · | $132.4K | $0 | |
| Gross Profit | · | · | · | · | · | · | · | · | · | · | $-130.7K | $40.1K | |
| R&D Expense | $21M | $14M | $17M | $15M | $9M | $7M | $7M | $4M | $2M | $770.4K | $2M | $1M | |
| SG&A Expense | $16M | $14M | $14M | $13M | $11M | $8M | $11M | $7M | $5M | $6M | $9M | $8M | |
| Operating Expenses | $37M | $28M | $31M | $28M | $21M | $15M | $17M | $11M | $8M | $8M | $13M | $12M | |
| Operating Income | $-37M | $-28M | $-31M | $-28M | $-21M | $-15M | $-17M | $-11M | $-8M | $-8M | $-13M | $-12M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | $15.8K | |
| Interest Income | $2M | $4M | $4M | $877.0K | $6.0K | · | · | · | · | · | · | $260 | |
| Other Non-op | $-6.0K | $-223.0K | $-70.0K | $-146.0K | $-91.0K | $51.0K | $25.6K | $29.3K | $154 | $2M | $431 | $260 | |
| Pretax Income | $-35M | $-26M | $-30M | $-27M | $-21M | $-18M | $-17M | $-11M | $-8M | $-6M | $-13M | $-12M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | $0 | |
| Net Income | $-35M | $-26M | $-30M | $-27M | $-21M | $-18M | $-17M | $-11M | $-8M | $-6M | $-16M | $-15M | |
| EPS (Basic) | $-4.04 | $-3.04 | $-0.24 | $-0.21 | $-0.18 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-4.04 | $-3.04 | $-0.24 | $-0.21 | · | · | · | · | · | · | · | · | |
| Shares (Basic) | 8,611,321 | 8,390,618 | 126,081,602 | 126,624,110 | 116,950,000 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 8,611,321 | 8,390,618 | 126,081,602 | 126,624,110 | · | · | · | · | · | · | · | · | |
| EBITDA | $-37M | $-28M | $-31M | $-28M | $-20M | $-15M | $-17M | $-11M | $-8M | $-8M | $-12M | $-14M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $41M | $71M | $88M | $111M | $136M | $40M | $13M | $10M | $7M | $3M | $4M | $9M | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | $298.0K | |
| Inventory | · | · | · | · | · | · | · | · | · | · | $0 | $9.3K | |
| Prepaid Expense | $1M | $1M | $2M | $1M | $2M | $2M | $862.3K | $509.8K | $250.9K | $171.6K | $193.3K | $194.0K | |
| Other Current Assets | · | · | · | $2M | $1M | $657.0K | $26.1K | $30.9K | $16.3K | · | $110.7K | $0 | |
| Current Assets | $46M | $74M | $92M | $118M | $141M | $43M | $14M | $12M | $8M | $3M | $4M | $9M | |
| PP&E (Net) | · | · | · | · | $20.0K | $21.0K | $34.4K | $54.5K | $11.5K | $55.1K | $171.6K | $136.7K | |
| PP&E (Gross) | · | · | · | · | $36.0K | $186.0K | $185.5K | $216.0K | $171.0K | $210.5K | $285.9K | $456.7K | |
| Accum. Depreciation | · | · | · | · | $16.0K | $165.0K | $151.2K | $162.0K | $160.0K | $155.4K | $114.3K | $320.0K | |
| Intangibles | · | · | · | · | $54.0K | $41.0K | $173.5K | $192.0K | $234.0K | $640.4K | $2M | $2M | |
| Other Non-current Assets | $2M | $2M | $2M | $635.0K | $22.0K | $17.0K | $17.2K | $17.2K | $178.9K | $194.2K | $76.3K | $48.2K | |
| Total Assets | $48M | $76M | $96M | $124M | $141M | $43M | $14M | $12M | $8M | $4M | $6M | $12M | |
| Accounts Payable | $4M | $679.0K | $806.0K | $3M | $2M | $2M | $293.2K | $353.3K | $334.9K | $254.3K | $814.4K | $513.0K | |
| Accrued Liabilities | $1M | $919.0K | $973.0K | $1M | $204.0K | $93.0K | $77.9K | $177.1K | $90.1K | $17.0K | $463.7K | $254.1K | |
| Current Liabilities | $8M | $5M | $5M | $6M | $3M | $16M | $1M | $3M | $1M | $1M | $3M | $2M | |
| Capital Leases | · | · | · | · | · | · | $11.1K | · | · | · | · | · | |
| Total Liabilities | $8M | $5M | $5M | $6M | $3M | $16M | $1M | $3M | · | $1M | $3M | $2M | |
| Common Stock | $2M | $2M | $23M | $23M | $23M | $9M | $2M | $1M | $477.3K | $56.8K | $32.7K | $24.6K | |
| Paid-in Capital | $286M | $283M | $256M | $251M | · | $130M | · | · | $72M | $60M | $55M | $45M | |
| Retained Earnings | $-247M | $-212M | $-186M | $-156M | $-129M | $-112M | $-94M | $-77M | $-65M | $-57M | $-51M | $-35M | |
| Treasury Stock | $1M | $1M | $1M | $0 | · | · | · | · | · | · | · | · | |
| AOCI | · | · | · | · | $0 | · | · | · | · | · | · | · | |
| Stockholders' Equity | $39M | $71M | $91M | $118M | $138M | $27M | $13M | $9M | $7M | $3M | $4M | $9M | |
| Liabilities + Equity | $48M | $76M | $96M | $124M | $141M | $43M | $14M | $12M | $8M | $4M | $6M | $12M | |
| Shares Outstanding | 8,611,361 | 8,611,266 | 125,304,064 | 126,624,110 | 126,624,000 | 47,550,000 | 9,130,984 | 5,846,552 | 2,651,952 | 3,786,913 | 2,177,151 | 24,564,058 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | $8.0K | $23.0K | $47.0K | $52.8K | $44.2K | $129.0K | $303.5K | $272.6K | $480.3K | |
| Stock-based Comp | $3M | $2M | $5M | $7M | · | · | · | · | · | · | $840.1K | $556.3K | |
| Amort. of Intangibles | · | · | · | · | · | $27.6K | $30.8K | $30.0K | $103.0K | · | · | · | |
| Other Non-cash | · | · | · | $6M | $4M | $6M | $8M | $2M | $1M | $690.8K | $694.3K | $3M | |
| Operating Cash Flow | $-30M | $-21M | $-21M | $-21M | $-16M | $-12M | $-9M | $-9M | $-7M | $-5M | $-14M | $-11M | |
| CapEx | $23.0K | $19.0K | $14.0K | $27.0K | $9.0K | $9.0K | $7.6K | $110.9K | · | · | · | · | |
| Investing Cash Flow | $-23.0K | $-19.0K | $-14.0K | $-5M | $-9.0K | $-9.0K | $-7.6K | $-110.9K | · | $-9.2K | $-288.4K | $-343.3K | |
| Stock Issued | · | · | · | · | · | · | · | · | $6M | $5M | $9M | $13M | |
| Stock Repurchased | · | $0 | $1M | $0 | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $0 | $-1M | · | · | · | · | · | $6M | $5M | $9M | · | |
| Financing Cash Flow | $0 | $4M | $-1M | $0 | $113M | $39M | $11M | $12M | $11M | $5M | · | · | |
| Net Change in Cash | $-30M | $-17M | $-22M | $-25M | $97M | $27M | $2M | $3M | $4M | $-687.9K | $-5M | $2M | |
| Free Cash Flow | $-30M | $-21M | $-21M | $-21M | $-16M | $-12M | $-9M | $-9M | · | · | · | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | · | · | · | -7431.9% | 35.2% | |
| Operating Margin | · | · | · | · | · | · | · | · | · | · | -725746.2% | -2784.0% | |
| Net Margin | · | · | · | · | · | · | · | · | · | · | -896491.6% | -2786.9% | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | -725721.7% | -2786.9% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | · | -710238.4% | -2676.7% | |
| ROA | -56.1% | -29.5% | -27.4% | -20.4% | -22.4% | -62.2% | -131.5% | -114.7% | -132.0% | -122.6% | -175.0% | -123.3% | |
| ROE | -71.7% | -35.1% | -31.8% | -22.3% | -14.8% | -96.3% | -122.4% | -117.7% | -161.9% | -186.3% | -238.1% | -145.8% | |
| ROIC | -94.4% | -38.6% | -34.5% | -23.5% | -14.9% | -53.8% | -131.2% | -129.9% | · | · | -341.0% | -154.2% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.5 | 15.0 | 17.6 | 21.2 | 45.2 | 2.7 | 10.8 | 4.0 | 6.4 | 3.1 | 1.7 | 4.1 | |
| Quick Ratio | 5.0 | 14.3 | 16.9 | 19.9 | 43.6 | 2.5 | 9.5 | 3.6 | 5.9 | 2.9 | 1.5 | 4.0 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | -928.6 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | |
| Inventory Turnover | · | · | · | · | · | · | · | · | · | · | 28.5 | 17.1 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | 2.4 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.57 | $0.55 | $0.73 | $0.93 | $1.09 | $0.57 | $1.44 | $1.51 | $0.22 | $0.82 | $0.11 | $0.39 | |
| Cash Flow / Share | $-3.46 | $-0.17 | $-0.17 | · | · | · | · | · | · | · | · | · | |
| Cash / Share | $4.80 | $0.55 | $0.71 | $0.88 | $1.08 | $0.83 | $1.38 | $1.78 | $0.23 | $0.80 | $0.11 | $0.35 | |
| EPS (TTM) | $-4.04 | $-3.04 | $-0.24 | $-0.21 | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $114.0K | $114.0K | $114.0K | $114.0K | $114.0K | $114.0K | $114.0K | $114.0K | $114.0K | $114.0K | $1.8K | $40.1K | |
| Net Income TTM | $-35M | $-26M | $-30M | $-27M | $-21M | $-18M | $-17M | $-11M | $-8M | $-6M | $-16M | $-15M | |
| Market Cap | $5M | $121M | $110M | $67M | $203M | $45M | $14M | $6M | $99M | $64M | $1.88B | $6.32B | |
| P/E | -0.1 | -0.3 | -3.7 | -2.5 | · | · | · | · | · | · | · | · | |
| P/S | 44.6 | 1064.9 | 967.1 | 588.6 | 1776.8 | 396.2 | 125.7 | 52.3 | 870.8 | 561.9 | 1069998.9 | 157526.2 | |
| P/B | 0.1 | 1.7 | 1.2 | 0.6 | 1.5 | 1.7 | 1.1 | 0.7 | 14.3 | 20.7 | 502.7 | 665.7 | |
| P / Tangible Book | 0.1 | 1.7 | 1.2 | 0.6 | 1.5 | 1.7 | · | · | · | · | · | · | |
| P / Cash Flow | -0.2 | -5.8 | -5.3 | -3.2 | -12.3 | -3.9 | -1.6 | -0.7 | -15.1 | -11.9 | -134.8 | -599.0 | |
| P / FCF | -0.2 | -5.8 | -5.3 | -3.2 | -12.3 | -3.9 | -1.6 | -0.7 | · | · | · | · | |
| Earnings Yield | -684.8% | -323.4% | -27.3% | -39.6% | · | · | · | · | · | · | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $5M | $5M | $6M | $5M | $6M | $4M | $3M | $3M | $4M | $4M | $6M | $4M | $4M | $4M | $5M | $5M | |
| SG&A Expense | $4M | $5M | $5M | $4M | $4M | $3M | $4M | $3M | $4M | $3M | $3M | $3M | $4M | $4M | $3M | $3M | |
| Operating Expenses | $9M | $10M | $11M | $9M | $9M | $7M | $7M | $6M | $7M | $7M | $9M | $7M | $8M | $7M | $8M | $8M | |
| Operating Income | $-9M | $-10M | $-11M | $-9M | $-9M | $-7M | $-7M | $-6M | $-7M | $-7M | $-9M | $-7M | $-8M | $-7M | $-8M | $-8M | |
| Interest Income | $227.0K | $309.0K | $442.0K | $570.0K | $645.0K | $720.0K | $838.0K | $1M | $1M | $1M | $1M | $1M | $983.0K | $850.0K | $671.0K | $194.0K | |
| Other Non-op | $-24.0K | $-28.0K | $57.0K | $-11.0K | $-28.0K | $-24.0K | $-34.0K | $-136.0K | $-17.0K | $-36.0K | $28.0K | $-35.0K | $-30.0K | $-33.0K | $-18.0K | $0 | |
| Pretax Income | $-8M | $-10M | $-11M | $-9M | $-8M | $-7M | $-6M | $-7M | $-6M | $-6M | $-8M | $-6M | $-10M | $-6M | $-7M | $-8M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-8M | $-10M | $-11M | $-9M | $-8M | $-7M | $-6M | $-7M | $-6M | $-6M | $-8M | $-6M | $-10M | $-6M | $-7M | $-8M | |
| EPS (Basic) | $-0.95 | $-1.11 | $-3.85 | $-0.07 | $-0.98 | $-0.78 | $-2.88 | $-0.06 | $-0.05 | $-0.05 | $-0.06 | $-0.05 | $-0.08 | $-0.05 | $-0.06 | $-0.06 | |
| EPS (Diluted) | $-0.95 | $-1.11 | $-3.85 | $-0.07 | $-0.98 | $-0.78 | $-2.88 | $-0.06 | $-0.05 | $-0.05 | $-0.06 | $-0.05 | $-0.08 | $-0.05 | · | · | |
| Shares (Basic) | 8,908,511 | 8,622,289 | · | 129,171,424 | 8,622,289 | 8,622,289 | · | 125,772,664 | 125,732,140 | 125,319,778 | · | 125,793,112 | 126,622,798 | 126,624,110 | · | 126,624,000 | |
| Shares (Diluted) | 8,908,511 | 8,622,289 | · | 129,171,424 | 8,622,289 | 8,622,289 | · | 125,772,664 | 125,732,140 | 125,319,778 | · | 125,793,112 | 126,622,798 | 126,624,110 | · | · | |
| EBITDA | $-9M | $-10M | · | $-9M | $-9M | $-7M | · | $-6M | $-7M | $-7M | · | $-7M | $-8M | $-7M | · | $-8M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $26M | $32M | $41M | $52M | $58M | $65M | $71M | $75M | $80M | $84M | $88M | $94M | $99M | $104M | $111M | $117M | |
| Prepaid Expense | $2M | $2M | $1M | $580.0K | $1M | $1M | $1M | $950.0K | $987.0K | $2M | $2M | $3M | $6M | $5M | $1M | $5M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $7.0K | $7.0K | $858.0K | · | $201.0K | |
| Current Assets | $31M | $37M | $46M | $56M | $63M | $69M | $74M | $77M | $82M | $87M | $92M | $98M | $106M | $111M | $118M | $123M | |
| Other Non-current Assets | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $642.0K | $631.0K | $635.0K | $629.0K | |
| Total Assets | $32M | $38M | $48M | $58M | $65M | $71M | $76M | $79M | $86M | $91M | $96M | $102M | $108M | $116M | $124M | $127M | |
| Accounts Payable | $2M | $3M | $4M | $4M | $2M | $1M | $679.0K | $2M | $1M | $1M | $806.0K | $718.0K | $1M | $1M | $3M | $2M | |
| Accrued Liabilities | $1M | $3M | $1M | $2M | $2M | $2M | $919.0K | $2M | $2M | $2M | $973.0K | $1M | $803.0K | $613.0K | $1M | $117.0K | |
| Current Liabilities | $5M | $7M | $8M | $8M | $7M | $5M | $5M | $6M | $6M | $5M | $5M | $3M | $3M | $3M | $6M | $3M | |
| Total Liabilities | $5M | $7M | $8M | $8M | $7M | $5M | $5M | $6M | $6M | $5M | $5M | $3M | $3M | $3M | $6M | $3M | |
| Common Stock | $2M | $2M | $2M | $23M | $23M | $23M | $2M | $23M | $23M | $23M | $23M | $23M | $23M | $23M | $23M | $23M | |
| Paid-in Capital | $291M | $287M | $286M | $263M | $263M | $262M | $283M | $258M | $257M | $257M | $256M | · | · | · | $251M | · | |
| Retained Earnings | $-265M | $-256M | $-247M | $-236M | $-227M | $-219M | $-212M | $-205M | $-198M | $-192M | $-186M | $-179M | $-172M | $-162M | $-156M | $-149M | |
| Treasury Stock | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $152.0K | · | $0 | · | |
| AOCI | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-54.0K | |
| Stockholders' Equity | $27M | $30M | $39M | $50M | $58M | $65M | $71M | $74M | $80M | $86M | $91M | $98M | $105M | $113M | $118M | $124M | |
| Liabilities + Equity | $32M | $38M | $48M | $58M | $65M | $71M | $76M | $79M | $86M | $91M | $96M | $102M | $108M | $116M | $124M | $127M | |
| Shares Outstanding | 9,979,298 | 8,611,361 | 8,611,361 | 129,171,424 | 129,171,424 | 129,170,004 | 8,611,266 | 125,304,064 | 125,304,064 | 125,507,814 | 125,304,064 | 125,304,000 | 126,505,000 | 126,624,000 | 126,624,110 | 126,624,000 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | · | $3.0K | $3.0K | $3.0K | · | $2.0K | |
| Stock-based Comp | $815.0K | $722.0K | $503.0K | $784.0K | $796.0K | $563.0K | $774.0K | $749.0K | $352.0K | $417.0K | $519.0K | $926.0K | $2M | $2M | · | · | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | · | · | · | · | $-744.0K | · | · | |
| Operating Cash Flow | $-10M | $-10M | $-11M | $-6M | $-7M | $-6M | $-7M | $-5M | $-5M | $-5M | $-6M | $-4M | $-4M | $-7M | $-5M | $-5M | |
| CapEx | $0 | $0 | $7.0K | $7.0K | $0 | $9.0K | $0 | $10.0K | $3.0K | $6.0K | $0 | $1.0K | $13.0K | $0 | $8.0K | $6.0K | |
| Investing Cash Flow | $0 | $0 | $-7.0K | $-7.0K | $0 | $-9.0K | $0 | $-10.0K | $-3.0K | $-6.0K | $0 | $-1.0K | $-13.0K | $0 | $-2M | $-3M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $0 | · | |
| Financing Cash Flow | $4M | $0 | $0 | $0 | $0 | $0 | $3M | $0 | $100.0K | $204.0K | $0 | $-1M | $0 | $0 | $0 | $0 | |
| Net Change in Cash | $-6M | $-10M | $-11M | $-6M | $-7M | $-6M | $-4M | $-5M | $-4M | $-4M | $-6M | $-5M | $-4M | $-7M | $-6M | $-8M | |
| Free Cash Flow | · | $-10M | · | · | · | $-6M | · | · | · | $-5M | · | · | · | $-7M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -17.5% | -17.6% | · | -12.6% | -11.2% | -8.3% | · | -8.0% | -6.2% | -5.7% | · | -5.5% | -8.1% | -5.0% | · | -5.9% | |
| ROE | -20.1% | -20.0% | · | -14.1% | -12.2% | -8.9% | · | -8.4% | -6.5% | -5.9% | · | -5.6% | -8.4% | -5.1% | · | -6.0% | |
| ROIC | -32.4% | -32.4% | · | -18.6% | -15.7% | -11.3% | · | -8.7% | -8.9% | -8.1% | · | -7.6% | -7.4% | -6.3% | · | -6.6% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.7 | 4.9 | · | 6.8 | 9.2 | 12.7 | · | 13.3 | 14.3 | 16.3 | · | 28.4 | 30.5 | 37.7 | · | 43.0 | |
| Quick Ratio | 4.8 | 4.3 | · | 6.3 | 8.5 | 12.0 | · | 12.9 | 14.0 | 15.8 | · | 27.3 | 28.6 | 35.3 | · | 40.9 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.69 | $3.54 | · | $0.39 | $0.45 | $0.51 | · | $0.59 | $0.64 | $0.68 | · | $0.78 | $0.83 | $0.89 | · | $0.98 | |
| Cash Flow / Share | · | $-1.11 | · | · | · | $-0.05 | · | · | · | $-0.04 | · | · | · | · | · | · | |
| Cash / Share | $2.61 | $3.68 | · | $0.40 | $0.45 | $0.50 | · | $0.60 | $0.63 | $0.67 | · | $0.75 | $0.79 | $0.82 | · | $0.93 | |
| EPS (TTM) | $-5.98 | $-6.01 | · | $-4.71 | $-4.70 | $-3.77 | · | $-0.22 | $-0.21 | $-0.24 | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-38M | $-38M | · | $-30M | $-29M | $-26M | · | $-27M | $-26M | $-30M | · | $-30M | $-32M | $-28M | · | $-24M | |
| Market Cap | $19M | $45M | · | $112M | $107M | $87M | · | $190M | $149M | $226M | · | $93M | $159M | $91M | · | $105M | |
| P/E | -0.3 | -0.9 | · | -2.8 | -2.6 | -2.7 | · | -103.6 | -85.0 | -112.5 | · | · | · | · | · | · | |
| P/B | 0.7 | 1.5 | · | 2.3 | 1.9 | 1.3 | · | 2.6 | 1.9 | 2.6 | · | 0.9 | 1.5 | 0.8 | · | 0.8 | |
| P / Tangible Book | 0.7 | 1.5 | · | 2.3 | 1.9 | 1.3 | · | 2.6 | 1.9 | 2.6 | · | 0.9 | 1.5 | 0.8 | · | 0.8 | |
| P / Cash Flow | · | -4.7 | · | · | · | -14.5 | · | · | · | -48.1 | · | · | · | -13.0 | · | · | |
| Earnings Yield | -309.8% | -114.3% | · | -36.1% | -37.8% | -37.5% | · | -0.96% | -1.2% | -0.89% | · | · | · | · | · | · |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Nettoergebnis | $-35M | $-26M | $-30M | $-27M | $-21M |
| Verwässerte EPS | $-4.04 | $-3.04 | $-0.24 | $-0.21 | · |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 5.5 | 15.0 | 17.6 | 21.2 | 45.2 |
| Quick Ratio | 5.0 | 14.3 | 16.9 | 19.9 | 43.6 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-30M | $-21M | $-21M | $-21M | $-16M |
Institutionelle Eigentümer (13F) 40 Einreicher · $6.4M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
40
Gehaltener Wert
$6.4M
Neue Positionen
7
Geschlossene Positionen
6
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 7 | 6 | 8 | 8 | · |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen. Änderung gegenüber Vorquartal nicht angezeigt: Die Einreicherabdeckung unterscheidet sich zwischen diesen beiden Quartalen zu stark für einen zuverlässigen Vergleich.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $3.627.225 | 6.147.838 | 56,95% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $698.172 | 361.747 | 10,96% | Aktien |
| AMERIPRISE FINANCIAL INC | $498.392 | 258.234 | 7,82% | Aktien |
| BlackRock, Inc. | $317.211 | 164.358 | 4,98% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $254.843 | 132.043 | 4,00% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $178.343 | 92.382 | 2,80% | Aktien |
| UBS Group AG | $159.456 | 82.620 | 2,50% | Aktien |
| JANE STREET GROUP, LLC | $109.242 | 56.602 | 1,72% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $101.485 | 52.583 | 1,59% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $89.760 | 46.508 | 1,41% | Aktien |
| STATE STREET CORP | $76.739 | 39.761 | 1,20% | Aktien |
| NORTHERN TRUST CORP | $39.081 | 20.249 | 0,61% | Aktien |
| Point72 Asia (Singapore) Pte. Ltd. | $38.240 | 44.106 | 0,60% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $30.058 | 15.574 | 0,47% | Aktien |
| WOLVERINE TRADING, LLC | $24.436 | 28.000 | 0,38% | Verkaufsoption |
| MORGAN STANLEY | $23.825 | 12.345 | 0,37% | Aktien |
| WOLVERINE TRADING, LLC | $23.825 | 27.300 | 0,37% | Kaufoption |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $21.809 | 11.300 | 0,34% | Kaufoption |
| WOLVERINE TRADING, LLC | $16.007 | 18.342 | 0,25% | Aktien |
| TWO SIGMA ADVISERS, LP | $10.797 | 18.300 | 0,17% | Aktien |
| GREENBERG FINANCIAL GROUP | $10.747 | 18.216 | 0,17% | Aktien |
| Vanguard Global Advisers, LLC | $5.962 | 3.089 | 0,09% | Aktien |
| ROYAL BANK OF CANADA | $4.000 | 1.994 | 0,06% | Aktien |
| JONES FINANCIAL COMPANIES LLLP | $3.875 | 2.061 | 0,06% | Aktien |
| MCF Advisors LLC | $2.058 | 1.066 | 0,03% | Aktien |
| OSAIC HOLDINGS, INC. | $1.131 | 587 | 0,02% | Aktien |
| JPMORGAN CHASE & CO | $772 | 390 | 0,01% | Aktien |
| Rockefeller Capital Management L.P. | $643 | 333 | 0,01% | Aktien |
| WELLS FARGO & COMPANY/MN | $440 | 228 | 0,01% | Aktien |
| SBI Securities Co., Ltd. | $286 | 148 | 0,00% | Aktien |
| HARBOUR INVESTMENTS, INC. | $212 | 110 | 0,00% | Aktien |
| TD Waterhouse Canada Inc. | $210 | 103 | 0,00% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $168 | 87 | 0,00% | Aktien |
| GROUP ONE TRADING LLC | $104 | 54 | 0,00% | Aktien |
| Point72 (DIFC) Ltd | $71 | 82 | 0,00% | Aktien |
| Caitong International Asset Management Co., Ltd | $12 | 6 | 0,00% | Aktien |
| Napier Financial, LLC | $12 | 6 | 0,00% | Aktien |
| Bogart Wealth, LLC | $10 | 5 | 0,00% | Aktien |
| Clearstead Advisors, LLC | $8 | 4 | 0,00% | Aktien |
| BESSEMER GROUP INC | $0 | 6 | 0,00% | Aktien |
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Steven C. Quay, Shu-Chih Chen ×2 Einreichungen | 28. Januar 2016 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 18 Insider · 10 Führungskräfte · 10 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Steven C Quay | President & CEO | 27. März 2026 A | 88.038 | 0 | 0 | $0 |
| Mark James Daniel | Chief Financial Officer | 26. März 2026 A | 63.000 | 0 | 0 | $0 |
| Heather Rees | Chief Financial Officer | 15. Mai 2025 A | · | 0 | 0 | $0 |
| Gregory L Weaver | Former EVP, CFO, & Director | 15. November 2023 S | 55 | 0 | 0 | $0 |
| Kyle Guse | CFO, Gen Counsel and Secretary | 2. März 2023 A | 10.000 | 0 | 0 | $0 |
| Scott Youmans | Chief Operating Officer | 1. September 2015 A | · | 0 | 0 | $0 |
| Christopher S. Destro | SVP, Sales and Marketing | 16. März 2015 A | · | 0 | 0 | $0 |
| John E Sawyer | SVP, Global Regulatory Affairs and Quality Assurance | 16. März 2015 A | · | 0 | 0 | $0 |
| Peter J. Carbonaro | Sr. Vice President, Operations | 6. Mai 2014 A | · | 0 | 0 | $0 |
| Ben R Chen | Sr. VP of Glob. Reg. Affairs | 1. April 2014 A | · | 0 | 0 | $0 |
| Tessa Cigler | Direktor | 12. Mai 2026 A | 10.000 | 0 | 0 | $0 |
| Jonathan Finn | Direktor | 12. Mai 2026 A | 11.666 | 0 | 0 | $0 |
| Shu-Chih Chen | Direktor | 12. Mai 2026 A | 10.000 | 0 | 0 | $0 |
| Stephen J Galli | Direktor | 12. Mai 2026 A | 10.006 | 0 | 0 | $0 |
| Lawrence H. Remmel | Direktor | 12. Mai 2026 A | 10.683 | 0 | 0 | $0 |
| Richard I Steinhart | Direktor | 12. Mai 2026 A | 10.000 | 0 | 0 | $0 |
| Alexander D Cross | Direktor | 15. Mai 2013 P | 88.866 | 0 | 0 | $0 |
| John Barnhart | Direktor | 7. Mai 2013 A | · | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 3 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
ATOS Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 8 Analysten
KAUF
Median-Ziel
$22.00
+840,2%
2 25,0%
Starker Kauf
5 62,5%
Kauf
1 12,5%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
3 Analysten · 2026-09-27Mittelwert-Ziel $18.67 +697,7%
← Unter allen Zielen
Aktueller Preis $2.34
Tief$10.00
Mittelwert$18.67
Hoch$24.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 7, 2026